tradingkey.logo
tradingkey.logo
検索

AtriCure Inc

ATRC
ウォッチリストに追加
31.345USD
+1.615+5.43%
終値 07/02, 13:00ET15分遅れの株価
1.56B時価総額
損失額直近12ヶ月PER

詳細情報 AtriCure Inc 企業名

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Incの企業情報

企業コードATRC
会社名AtriCure Inc
上場日Aug 05, 2005
最高経営責任者「CEO」Carrel (Michael H)
従業員数1300
証券種類Ordinary Share
決算期末Aug 05
本社所在地7555 Innovation Way
都市MASON
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号45040
電話番号15137554100
ウェブサイトhttps://www.atricure.com
企業コードATRC
上場日Aug 05, 2005
最高経営責任者「CEO」Carrel (Michael H)

AtriCure Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
40.52K
+15.16%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
39.86K
+15.41%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
28.33K
+21.69%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
24.66K
+24.92%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%

よくある質問

AtriCure Incの上位5名の株主は誰ですか?

AtriCure Incの上位5名の株主は以下のとおりです。Mr. Michael H. (Mike) Carrel, CPA

AtriCure Inc(ATRC)の株式を保有している機関の数はいくつですか?

2026Q1時点で、AtriCure Incの株式を保有している機関は505社あり、保有株式の総市場価値は約48.18Mで、全体の95.14%を占めています。2025Q4と比較して、機関の持ち株は-7010307.00増加しています。

AtriCure Incの最大の収益源は何ですか?

2026Q1において、Appendage Management-United states部門がAtriCure Incにとって最大の収益を生み出しており、その金額は178.13Mで、全収益の33.32%を占めています。